Current Report Filing (8-k)
01 May 2021 - 7:13AM
Edgar (US Regulatory)
SECURITIES
AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
Pursuant
to Section 13 or 15(d) of
the
Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): April 30, 2021
AMERICAN
CANNABIS COMPANY, INC.
(Exact Name
of Registrant as Specified in its Charter)
Delaware
(State
or other jurisdiction of incorporation or organization)
|
Commission
File Number
000-26108
|
90-1116625
(I.R.S.
Employer
Identification
Number)
|
2590
Walnut Street #6, Denver, Colorado 80205
(Address
of Principal Executive Offices and Zip Code)
(303)
974-4770
(Issuer's
telephone number)
(Former
Name or Former Address, if Changed Since Last Report)
Check the appropriate box
below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
provisions:
[ ] Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant
to Section 12(b) of the Act:
Title
of Each Class
|
Trading
Symbols
|
Name
of Exchange on Which Registered
|
Common
|
AMMJ
|
None
|
Indicate by check mark whether
the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule
12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth
company [ ]
If an emerging growth company,
indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Section
2 - Financial Information Item 2.01
Completion
of Acquisition or Disposition of Assets.
On
April 30, 2021, the Colorado MED and the City of Colorado Springs granted approval for the change of ownership, and the registrant
completed an asset purchase agreement with Medihemp, LLC (“Medihemp”) and its wholly owned subsidiary SLAM Enterprises,
LLC (“SLAM”), and Medical Cannabis Caregivers, Inc. (“Medical Cannabis”), each an entity organized and
operating under the laws of the State of Colorado, and all doing business as “Naturaleaf.” No material relationship
exists, other than in respect of the transaction, between Medihemp, SLAM and Medical Cannabis, and the registrant or any of its
affiliates, or any director or officer of the registrant, or any associate of any such director or officer.
Medihemp
and SLAM respectively own fixed assets and operate two retail Medical Marijuana Centers located at 1004 S. Tejon Street, Colorado
Springs, CO 80903, and 2727 Palmer Park Blvd. Suite A, Colorado Springs, CO 80909.
Medical
Cannabis owns fixed assets and operates a retail Medical Marijuana Center located at 5875 Lehman Drive, Ste. 100, Colorado Springs,
CO 80918.
Medical
Cannabis also owns and operates a Medical Marijuana Optional Premises Cultivation license, and a Medical Marijuana-Infused Product
Manufacturer license, along with fixed assets all located at 2611 Durango Drive, Colorado Springs, CO 80910.
By
virtue of the closing of the asset purchase agreement, the Registrant agreed to purchase, and Medihemp, SLAM, and Medical Cannabis
agreed to sell and/or assign to the Registrant, all of their respective fixed assets and associated intellectual property, including
assignment of the following licenses issued by the Colorado Marijuana Enforcement Division (“MED”) and the corresponding
City of Colorado Springs (“City”):
|
o
|
Medihemp’s,
SLAM’s and Medical Cannabis’ respective Medical Marijuana Center licenses;
|
|
o
|
Medical
Cannabis’ Medical Marijuana Infused Product Manufacturer license; and,
|
|
o
|
Medical
Cannabis’ Medical Marijuana Optional Premises Cultivation license.
|
As
part of the transaction, the Registrant assumed leases for Medihemp, SLAM, and Medical Cannabis’ respective retail Medical
Marijuana Centers. The Registrant entered into a separate lease for Medical Cannabis’ Durango Drive facility.
The
purchase price for the acquisition is $2.2 million dollars and the issuance of 3 million shares of the Registrant’s restricted
common stock. Payment terms required a $20,000 non-refundable payment upon signing, which the registrant made, a cash payment
of $1,080,000 after the receipt of the Contingent Approval Letters of the Change of Ownership applications from the MED and City,
and the balance of $1,100,000 paid pursuant to a promissory note executed by Registrant effective
upon receipt of the Contingent Approval Letters. The maturity date of the Promissory Note is 365 days from the Closing Date, includes
10% simple interest accruing annually, and is not subject to a pre-payment penalty. The transaction documents are incorporated
herein by reference from the registrant’s Form 8-K filed March 12, 2021.
Item
3.02 Unregistered Sales of Equity Securities.
Pursuant
to the material definitive agreement disclosed on Form 8-K March 12, 2021, and as partial consideration for the asset purchase
transaction, the registrant on April 29, 2021 issued three million (3,000,000) shares of restricted unregistered common stock
to Roger Scott Saunders, the sole affiliate and control person of Medical Cannabis, Medihemp and SLAMM.
The
registrant issued the above shares of its common stock pursuant to the exemption from the registration requirements of the Securities
Act of 1933, as amended, available to the registrant by Section 4(a)(2) promulgated thereunder due to the fact that it was an
isolated issuance and did not involve a public offering of securities. The three million shares issued are less than 5% of the
registrants issued and outstanding stock as of the date of its last periodic report.
The
registrant will amend this Form 8-K to disclose pro forma financial statements for the acquired assets within 71 days of the filing
date of this 8-K.
Section
9 – Financial Statement and Exhibits
Item
9.01 Financial Statements and Exhibits
Pursuant to
the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
Dated April
30, 2021
AMERICAN CANNABIS
COMPANY, INC.
(Registrant)
By: /s/ Terry
Buffalo
Terry Buffalo
Principal
Executive Officer
American Cannabis (CE) (USOTC:AMMJ)
Historical Stock Chart
From Feb 2025 to Mar 2025
American Cannabis (CE) (USOTC:AMMJ)
Historical Stock Chart
From Mar 2024 to Mar 2025